PD-1/PD-L1-IN-29
Modify Date: 2024-04-06 13:29:12
PD-1/PD-L1-IN-29 structure
|
Common Name | PD-1/PD-L1-IN-29 | ||
|---|---|---|---|---|
| CAS Number | 2665734-13-2 | Molecular Weight | 460.48 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H24N2O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PD-1/PD-L1-IN-29PD-1/PD-L1-IN-29 (S4-1) is a potent PD-1/PD-L1 inhibitor with an IC50 value of 6.1 nM. PD-1/PD-L1-IN-29 binds PD-L1 and disrupts PD-1/PD-L1 interactions, induces PD-L1 dimerization and internalization, improves its localization to the endoplasmic reticulum, and promotes PD-L1 entry into the endoplasmic reticulum. PD-1/PD-L1-IN-29 has anticancer activity[1]. |
| Name | PD-1/PD-L1-IN-29 |
|---|
| Description | PD-1/PD-L1-IN-29 (S4-1) is a potent PD-1/PD-L1 inhibitor with an IC50 value of 6.1 nM. PD-1/PD-L1-IN-29 binds PD-L1 and disrupts PD-1/PD-L1 interactions, induces PD-L1 dimerization and internalization, improves its localization to the endoplasmic reticulum, and promotes PD-L1 entry into the endoplasmic reticulum. PD-1/PD-L1-IN-29 has anticancer activity[1]. |
|---|---|
| Related Catalog | |
| In Vitro | PD-1/PD-L1-IN-29(S4-1)(10 or 20 μM, 48 h) 可以通过阻断 PD-1/PD-L1 相互作用，恢复 PBMCs 的活化状态，增加 PBMCs 对A375 肿瘤细胞的细胞毒性，而对肿瘤细胞的直接杀伤作用很小[1]。 |
| In Vivo | PD-1/PD-L1-IN-29(S4-1)(10 or 25 mg/kg, i.p., 12 days) 在 MC38 结直肠肿瘤小鼠模型中，可以显著抑制肿瘤的生长，低剂量组和高剂量组（10 和 25 mg/kg）均可观察到，且抑制率分别为 65.9% 和 88.8%[1]。 |
| References |
| Molecular Formula | C26H24N2O6 |
|---|---|
| Molecular Weight | 460.48 |